Boston Scientific stock falls as cyberattack clouds 2026 outlook

Published on 09/11/2026 at 16:22 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Boston Scientific stock fell 4.14 percent to USD 43.10 on September 10, 2026. Revenue was USD 5.44 billion in Q2 2026 and EPS was USD 0.86.

Sterile Fertigungslinie für Herzkathetersysteme in einem Medizintechnik-Reinraum in Marlborough MA — Boston Scientific Corp. betreibt sterile Reinraumfertigung für Herzkathetersysteme am Standort Marlborough MA, ISIN US10117L1017, Illustration mit AI erstellt.

Boston Scientific stock (ISIN US10117L1017) fell 4.14 percent to USD 43.10 on September 10, 2026, after a cyberattack forced the company to cut its 2026 outlook. The shares closed 60.12 percent below the 52-week high of USD 108.07, and the company said it restored manufacturing, order fulfillment and shipping operations.

Q2 2026 still set the pace

According to MarketBeat, Boston Scientific reported Q2 2026 revenue of USD 5.44 billion and earnings per share of USD 0.86, which topped consensus by USD 0.03. Revenue rose 7.5 percent from the prior year period, while the company set Q3 2026 EPS guidance at USD 0.800 to USD 0.820.

Those figures matter because the same report also shows FY 2026 guidance of USD 3.280 to USD 3.320 per share, with analysts expecting about USD 3.3. The gap is now less about the model and more about execution after the cyber disruption.

Operations and the stock reaction

WSJ reported on September 10, 2026 that Boston Scientific restored key manufacturing and shipping operations after the cyberattack, while MarketWatch said the shares traded 60.12 percent below the 52-week high of USD 108.07. A first.

For investors, the key point is the trade-off: Q2 2026 still showed USD 5.44 billion in revenue and USD 0.86 in EPS, but the market is now pricing in the impact of a disrupted quarter and a narrower 2026 path.

Price and setup

Boston Scientific stock closed at USD 43.10 on September 10, 2026, down USD 1.86 on the day, with the latest quoted move marked at -4.14 percent. The stock is now far away from its 52-week high of USD 108.07, and that distance is what defines the setup.